(GGG) Graco - Overview
Stock: Pumps, Sprayers, Dispensers, Valves, Meters
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.33% |
| Yield on Cost 5y | 1.65% |
| Yield CAGR 5y | 9.97% |
| Payout Consistency | 90.3% |
| Payout Ratio | 31.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 20.1% |
| Relative Tail Risk | -3.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.43 |
| Alpha | -1.67 |
| Character TTM | |
|---|---|
| Beta | 0.751 |
| Beta Downside | 0.747 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.83% |
| CAGR/Max DD | 0.52 |
Description: GGG Graco January 03, 2026
Graco Inc. (NYSE:GGG) designs, manufactures, and markets fluid-handling systems that move, measure, mix, control, dispense, and spray liquids and powders across four global regions. Its three operating segments are: Contractor – sprayers and proportioning equipment for paint, foam, and road-marking applications; Industrial – pumps, meters, and precision dispensing tools for sealants, composites, and powder-coating systems (including the Gema and SAT brands); Process – pumps, valves, and lubrication solutions for chemicals, oil & gas, water, food, and automotive service markets.
Key data points: FY 2023 revenue was roughly $1.6 billion with an adjusted operating margin near 12%, and the company reported a parts-and-service backlog of about $400 million, indicating recurring revenue stability. Growth is tied to macro drivers such as U.S. housing starts (+4% YoY) and global infrastructure spending, which boost demand for spray-foam and road-marking equipment, while the broader industrial automation trend supports higher adoption of precision dispensing and composite-manufacturing tools. Graco’s exposure to the oil-field services market adds sensitivity to energy price cycles, but its diversified customer base across construction, automotive, and manufacturing mitigates concentration risk.
For a deeper quantitative assessment, you may find ValueRay’s analyst dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 521.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 3.08 > 1.0 |
| NWC/Revenue: 44.92% < 20% (prev 51.65%; Δ -6.74% < -1%) |
| CFO/TA 0.21 > 3% & CFO 683.6m > Net Income 521.8m |
| Net Debt (-563.1m) to EBITDA (751.5m): -0.75 < 3 |
| Current Ratio: 3.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (168.1m) vs 12m ago -2.59% < -2% |
| Gross Margin: 52.45% > 18% (prev 0.53%; Δ 5192 % > 0.5%) |
| Asset Turnover: 69.75% > 50% (prev 67.32%; Δ 2.43% > 0%) |
| Interest Coverage Ratio: 222.6 > 6 (EBITDA TTM 751.5m / Interest Expense TTM 2.89m) |
Altman Z'' 7.62
| A: 0.31 (Total Current Assets 1.47b - Total Current Liabilities 467.3m) / Total Assets 3.27b |
| B: 0.44 (Retained Earnings 1.46b / Total Assets 3.27b) |
| C: 0.20 (EBIT TTM 644.1m / Avg Total Assets 3.21b) |
| D: 2.67 (Book Value of Equity 1.66b / Total Liabilities 620.3m) |
| Altman-Z'' Score: 7.62 = AAA |
Beneish M -2.91
| DSRI: 1.03 (Receivables 393.8m/362.5m, Revenue 2.24b/2.11b) |
| GMI: 1.01 (GM 52.45% / 53.11%) |
| AQI: 1.15 (AQ_t 0.31 / AQ_t-1 0.27) |
| SGI: 1.06 (Revenue 2.24b / 2.11b) |
| TATA: -0.05 (NI 521.8m - CFO 683.6m) / TA 3.27b) |
| Beneish M-Score: -2.91 (Cap -4..+1) = A |
What is the price of GGG shares?
Over the past week, the price has changed by +6.22%, over one month by +9.86%, over three months by +14.57% and over the past year by +11.59%.
Is GGG a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GGG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 95.3 | 2.8% |
| Analysts Target Price | 95.3 | 2.8% |
| ValueRay Target Price | 100.2 | 8.1% |
GGG Fundamental Data Overview January 31, 2026
P/E Forward = 27.248
P/S = 6.4636
P/B = 5.4712
P/EG = 2.7013
Revenue TTM = 2.24b USD
EBIT TTM = 644.1m USD
EBITDA TTM = 751.5m USD
Long Term Debt = 36.3m USD (estimated: total debt 61.0m - short term 24.7m)
Short Term Debt = 24.7m USD (from shortTermDebt, last quarter)
Debt = 61.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -563.1m USD (from netDebt column, last quarter)
Enterprise Value = 13.89b USD (14.46b + Debt 61.0m - CCE 624.1m)
Interest Coverage Ratio = 222.6 (Ebit TTM 644.1m / Interest Expense TTM 2.89m)
EV/FCF = 21.78x (Enterprise Value 13.89b / FCF TTM 637.9m)
FCF Yield = 4.59% (FCF TTM 637.9m / Enterprise Value 13.89b)
FCF Margin = 28.52% (FCF TTM 637.9m / Revenue TTM 2.24b)
Net Margin = 23.33% (Net Income TTM 521.8m / Revenue TTM 2.24b)
Gross Margin = 52.45% ((Revenue TTM 2.24b - Cost of Revenue TTM 1.06b) / Revenue TTM)
Gross Margin QoQ = 51.71% (prev 53.23%)
Tobins Q-Ratio = 4.24 (Enterprise Value 13.89b / Total Assets 3.27b)
Interest Expense / Debt = 1.34% (Interest Expense 814.0k / Debt 61.0m)
Taxrate = 18.75% (30.6m / 163.1m)
NOPAT = 523.3m (EBIT 644.1m * (1 - 18.75%))
Current Ratio = 3.15 (Total Current Assets 1.47b / Total Current Liabilities 467.3m)
Debt / Equity = 0.02 (Debt 61.0m / totalStockholderEquity, last quarter 2.65b)
Debt / EBITDA = -0.75 (Net Debt -563.1m / EBITDA 751.5m)
Debt / FCF = -0.88 (Net Debt -563.1m / FCF TTM 637.9m)
Total Stockholder Equity = 2.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.27% (Net Income 521.8m / Total Assets 3.27b)
RoE = 20.38% (Net Income TTM 521.8m / Total Stockholder Equity 2.56b)
RoCE = 24.80% (EBIT 644.1m / Capital Employed (Equity 2.56b + L.T.Debt 36.3m))
RoIC = 20.44% (NOPAT 523.3m / Invested Capital 2.56b)
WACC = 8.65% (E(14.46b)/V(14.52b) * Re(8.68%) + D(61.0m)/V(14.52b) * Rd(1.34%) * (1-Tc(0.19)))
Discount Rate = 8.68% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -1.08%
[DCF Debug] Terminal Value 79.18% ; FCFF base≈588.7m ; Y1≈726.2m ; Y5≈1.24b
Fair Price DCF = 114.8 (EV 18.47b - Net Debt -563.1m = Equity 19.03b / Shares 165.8m; r=8.65% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 39.95 | EPS CAGR: 8.35% | SUE: 0.06 | # QB: 0
Revenue Correlation: 35.37 | Revenue CAGR: 4.98% | SUE: 0.14 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.74 | Chg30d=+0.004 | Revisions Net=+0 | Analysts=11
EPS current Year (2026-12-31): EPS=3.18 | Chg30d=+0.006 | Revisions Net=-3 | Growth EPS=+7.8% | Growth Revenue=+5.7%
EPS next Year (2027-12-31): EPS=3.46 | Chg30d=-0.040 | Revisions Net=+0 | Growth EPS=+8.6% | Growth Revenue=+4.7%